Merger Notification - Announcement according to § 10 Cartel Act
Pfizer Inc.; Biohaven Pharmaceutical Holding Company Ltd.
BWB/Z-5970
On 25.05.2022 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Pfizer Inc. (USA) intends to acquire 100% of the shares in and sole control over Biohaven Pharmaceutical Holding Company Ltd. (USA). The concentration concerns pharmaceutical assets for the treatment of migraine.
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 22.06.2022.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 23.06.2022 .